Bryn Pharma, Inc. of LEBANON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-30. The offering totals $15.0M, of which $9.3M was reported sold. Industry: Other Health Care.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Rick Schaden | Director | Beverly Hills, CA |
| Anne Whitaker | Director | Lebanon, NJ |
| Michael Kaseta | Director | Lebanon, NJ |
| Jeff Hartness | Director | Lebanon, NJ |
| Steven Hartman | Director | Lebanon, NJ |
| Steven Hartman | Executive Officer | Lebanon, NJ |
| Joshua Ziel | Executive Officer | Lebanon, NJ |
| Michelle Lobel | Director | Lebanon, NJ |
| Michelle Lobel | Executive Officer | Lebanon, NJ |
| Steven Killmeyer | Executive Officer | Lebanon, NJ |
| Marc Rapaport | Director | El Segundo, CA |
| Lisa Licht | Director | Lebanon, NJ |
| Sandra Loreaux | Director | Lebanon, NJ |
| James Borneman | Executive Officer | Lebanon, NJ |
| Kate Soper Diaz | Director | Lebanon, NJ |
| William Humphries | Director | Wayne, PA |
| David Dworaczyk | Director | Raleigh, NC |
| David Dworaczyk | Executive Officer | Raleigh, NC |
| Steve Killmeyer | Executive Officer | Raleigh, NC |
| Sandy Loreaux | Director | Raleigh, NC |
| Sandy Loreaux | Executive Officer | Raleigh, NC |
| Jim Borneman | Executive Officer | Raleigh, NC |
| Katherine Grell | Director | Raleigh, NC |
| Robert Yanez | Executive Officer | Raleigh, NC |
| Kate Grell | Director | Raleigh, NC |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-08-14 | D | $4.7M | $4.7M |
| 2023-07-05 | D/A | $30.0M | $26.7M |
| 2023-05-10 | D | $20.0M | $15.0M |
| 2022-10-11 | D/A | $50.0M | $43.5M |
| 2021-12-17 | D/A | $30.0M | $28.3M |
| 2021-07-20 | D | $15.0M | $5.2M |
| 2020-06-22 | D/A | $35.0M | $26.0M |
| 2019-11-04 | D | $15.0M | $15.0M |
| 2019-02-21 | D | $18.0M | $17.2M |